LV12627A - Aqueous prolonged release formulation - Google Patents

Aqueous prolonged release formulation

Info

Publication number
LV12627A
LV12627A LV000165A LV000165A LV12627A LV 12627 A LV12627 A LV 12627A LV 000165 A LV000165 A LV 000165A LV 000165 A LV000165 A LV 000165A LV 12627 A LV12627 A LV 12627A
Authority
LV
Latvia
Prior art keywords
prolonged release
sustained
release formulation
release
aqueous
Prior art date
Application number
LV000165A
Other languages
English (en)
Other versions
LV12627B (lv
Inventor
Michael J Hageman
Margaret L Possert
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of LV12627A publication Critical patent/LV12627A/lv
Publication of LV12627B publication Critical patent/LV12627B/lv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/27Growth hormone [GH], i.e. somatotropin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LVP-00-165A 1994-01-25 2000-12-01 Kompozīcija uz ūdens bāzes ar ilgstošu aktīvās vielas atbrīvošanos LV12627B (lv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18657294A 1994-01-25 1994-01-25

Publications (2)

Publication Number Publication Date
LV12627A true LV12627A (lv) 2001-03-20
LV12627B LV12627B (lv) 2001-08-20

Family

ID=22685468

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-00-165A LV12627B (lv) 1994-01-25 2000-12-01 Kompozīcija uz ūdens bāzes ar ilgstošu aktīvās vielas atbrīvošanos

Country Status (18)

Country Link
US (2) US6471977B1 (lv)
EP (1) EP0741579B1 (lv)
JP (1) JPH09508118A (lv)
KR (1) KR100355517B1 (lv)
CN (1) CN1139385A (lv)
AT (1) ATE187077T1 (lv)
AU (1) AU699746B2 (lv)
CA (1) CA2178610A1 (lv)
DE (1) DE69513635T2 (lv)
DK (1) DK0741579T3 (lv)
ES (1) ES2139881T3 (lv)
GR (1) GR3032727T3 (lv)
LV (1) LV12627B (lv)
MX (1) MX9602943A (lv)
NZ (1) NZ278770A (lv)
SI (1) SI0741579T1 (lv)
WO (1) WO1995019787A1 (lv)
ZA (1) ZA949350B (lv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA949350B (en) * 1994-01-25 1996-05-24 Upjohn Co Aqueous prolonged release formulation
CN1130222C (zh) 1996-01-11 2003-12-10 法玛西雅厄普约翰美国公司 水性延长释放配剂
US7319032B2 (en) * 2004-04-22 2008-01-15 Medtox Non-sugar sweeteners for use in test devices
AU2021396978A1 (en) 2020-12-08 2023-02-23 Ruminant Biotech Corp Limited Improvements to devices and methods for delivery of substances to animals

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4118380A (en) 1977-07-25 1978-10-03 Ayerst, Mckenna & Harrison Limited Decapeptide analogs of somatostatin
EP0140255B1 (en) 1983-10-14 1991-05-15 Sumitomo Pharmaceuticals Company, Limited Sustained-release injections
US4774091A (en) 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
US4985404A (en) 1984-10-04 1991-01-15 Monsanto Company Prolonged release of biologically active polypeptides
ES8702440A1 (es) 1984-10-04 1986-12-16 Monsanto Co Un procedimiento para la preparacion de una composicion de polipeptido inyectable sustancialmente no acuosa.
EP0193917A3 (en) 1985-03-06 1987-09-23 American Cyanamid Company Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration
PT83095B (en) * 1985-07-30 1987-12-23 Int Minerals & Chem Corp Method for the stabilization of growth promoting hormones using polyoxyethylene-polyoxypropylene copolymers
US4977140A (en) 1985-08-23 1990-12-11 Eli Lilly And Company Injectable sustained release formulation
US4816568A (en) 1986-05-16 1989-03-28 International Minerals & Chemical Corp. Stabilization of growth hormones
US4857506A (en) 1987-01-12 1989-08-15 American Cyanamid Company Sustained release growth hormone compositions for parenteral administration and their use
US4863736A (en) * 1987-03-16 1989-09-05 Monsanto Company Somatotropin prolonged release
US4888416A (en) * 1987-03-30 1989-12-19 International Minerals & Chemical Corp. Method for stabilizing somatotropins
EP0353045B1 (en) 1988-07-26 1995-11-15 Rutgers, The State University of New Jersey Devices and methods for growth promotion in poultry roasters
EP0374120A3 (en) 1988-12-13 1991-07-31 Monsanto Company Comosition for controlled release of polypeptides
US5015627A (en) 1990-07-20 1991-05-14 Smithkline Beecham Corporation Stabilized somatotropin for parenteral administration
US5169834A (en) 1990-11-30 1992-12-08 American Cyanamid Company Compositions and method for reducing vial breakage during lyophilization
US5198422A (en) 1992-06-11 1993-03-30 Smithkline Beecham Corporation Stabilized somatotropin for parenteral administration
ZA949350B (en) * 1994-01-25 1996-05-24 Upjohn Co Aqueous prolonged release formulation

Also Published As

Publication number Publication date
DE69513635D1 (de) 2000-01-05
DE69513635T2 (de) 2000-05-31
NZ278770A (en) 1997-09-22
EP0741579B1 (en) 1999-12-01
CN1139385A (zh) 1997-01-01
US20030220242A9 (en) 2003-11-27
CA2178610A1 (en) 1995-07-27
US6471977B1 (en) 2002-10-29
ATE187077T1 (de) 1999-12-15
GR3032727T3 (en) 2000-06-30
JPH09508118A (ja) 1997-08-19
EP0741579A1 (en) 1996-11-13
AU1521395A (en) 1995-08-08
US20030092625A1 (en) 2003-05-15
ZA949350B (en) 1996-05-24
DK0741579T3 (da) 2000-05-15
KR100355517B1 (ko) 2003-03-04
LV12627B (lv) 2001-08-20
ES2139881T3 (es) 2000-02-16
AU699746B2 (en) 1998-12-10
SI0741579T1 (en) 2000-04-30
US6699490B2 (en) 2004-03-02
MX9602943A (es) 1997-06-28
WO1995019787A1 (en) 1995-07-27

Similar Documents

Publication Publication Date Title
BR9107206A (pt) Processo para produzir uma variante de proteina que evoca uma resposta imunogenica diminuida em animais,produtos obtidos,composicao e uso
PT822199E (pt) Polipeptidos monopegilados no terminal-n e metodo para a sua preparacao
ATE124997T1 (de) Enzymatische entfernung einer aminoterminalen proteinsequenz.
EA199901013A1 (ru) Гели пролонгированного действия
DK0506748T3 (da) Aminosyrer, peptider eller derivater deraf bundet til fedtstoffer
ES535032A0 (es) Procedimiento para preparar peptidos
DK32684A (da) Fremgangsmaade til fremstilling af 26,26,26,27,27,27-hexafluor-1alfa,25-dihydroxycholesterol og mellemprodukter til brug herfor
DK0951837T3 (da) Bioaktive peptider samt anvendelse og fremgangsmåde til fremstilling af sådanne
LV12627A (lv) Aqueous prolonged release formulation
ES2124229T3 (es) Factor anti-inflamatorio, metodo de aislamiento y uso.
DK76687D0 (da) Fremgangsmaade til fremstilling af indol-alfa-ketosyrer ud fra den tilsvarende alfa-aminosyre, navnlig til fremstilling af indolpyrodruesyre
BG97123A (bg) Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа
DE69737476D1 (de) Neuer galaninrezeptor
NO874109D0 (no) Salicylsyreamider, fremgangsmaate til deres fremstilling og deres anvendelse.
FI883589A0 (fi) Menetelmä tyydyttämättömien aminohappoyhdisteiden valmistamiseksi
DE69005451D1 (de) Somatotropinanaloge.
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
ATE414164T1 (de) Verfahren zur kontrolle der spaltung mit ompt protease
BG98888A (en) Method for the preparation of 3-acylestratrienes and acylbezenes
SE9604439D0 (sv) New receptor
DE69011702D1 (de) Derivate von Aminocarboxylsäure.
ES8702436A1 (es) Procedimiento para la sintesis de dipeptidos de n elevado a alfa-acil arginina de cadena grasa e hidrolizados de proteina como tensioactivos ionicos de accion antimicrobiana
RU93058416A (ru) Способ индуцирования иммунной реакции и композиции для этой цели